What does this research mean for the field?

Marcus Maurer was a prominent physician and scientist in the field of allergology and immunology, known for his exceptional communication skills. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The paper aims to celebrate the achievements and contributions of Marcus Maurer in the field of allergology and immunology.

March 16, 2026

Legends of Allergology/Immunology: Marcus Maurer (†)—Physician, Scientist, Allergist and Unbeatable Communicator

Key Points

The paper aims to celebrate the achievements and contributions of Marcus Maurer in the field of allergology and immunology.
Analysis of Marcus Maurer's professional affiliations and contributions to clinical immunology.
Overview of research grants received from various pharmaceutical companies.
Review of leadership roles in relevant allergy and immunology organizations.
Documented numerous research grants from multiple international pharmaceutical companies.
Outlined significant leadership roles within German and European allergy organizations.
Highlighted contributions to allergy education and clinical communications.

Abstract

L.K. has received research grants from Allergy Therapeutics/Bencard, Great Britain/Germany; ALK-Abelló, Denmark; Allergopharma, Germany; Aimmune, USA; ASIT Biotech, Belgium; AstraZeneca, Sweden; Bionorica, Germany; BioNTech, Germany; Biomay, Austria; Blueprint, USA; Boehringer Ingelheim, Germany; Celltrion, South Korea; Circassia, USA; Chiesi, Italy; Cytos, Switzerland; Curalogic, Denmark; HAL, Netherlands; Lofarma, Italy; Menarini, Italy; Viatris/Mylan, USA; Novartis, Switzerland; Leti, Spain; ROXALL, Germany; GlaxoSmithKline (GSK), Great Britain; Sanofi, France; Stallergenes, France; Thermofisher, USA and/or has served on the speaker's bureau or was consulting for the above mentioned pharmaceutical companies. L.K. is the current President of German Society of Allergology AeDA, Governance Committee Board Member and ENT Section Board Member of the European Academy for Allergy and Clinical Immunology (EAACI), Vice-President of German Academy for Allergy and Environmental Medicine, Head of the Steering Committee of the German National CRS Registry (GENRE-CRS) and Editor-in-Chief of AllergoJournal and AllergoJournal International. M.M. has been an investigator for Amgen, Astra Zeneca, Celldex, Escient, Galderma, Incyte, Jasper, Novartis, Sanofi, Third Harmonic Bio, and received honoraria as a speaker and/or advisor from AbbVie, Advanz, ALK Abelló, Allegria, Almirall, Amgen, Argenx, Astra Zeneca, Astria, Attovia, Bambusa, Berlin-Chemie, Blueprint, Celldex, Celltrion, DeepApple, Enanta, Escient, FatiAbGen, Ga2len, Galderma, Granular, GSK, Incyte, Japan Tobacco, Jasper, Lilly, Lycia, Novartis, Pfizer, Pharvaris, Proinnovera, Regeneron, Sanofi, Santa Ana Bio, Septerna, Teva, Third Harmonic Bio, Vifor. T. Zuberbier has received institutional funding for research and/or honoria for lectures and/or consulting from Amgen, AstraZeneca, AbbVie, ALK, Almirall, Astellas, Bayer Health Care, Bencard, Berlin Chemie, Blueprint Medicine, FAES, HAL, Henkel, Kryolan, Leti, L'Oreal, Meda, Menarini, Merck, MSD, Novartis, Pfizer, Sanofi, Stallergenes, Takeda, Teva and UCB, Uriach, and Viatris; in addition, he is a member of ARIA, DGAKI, ECARF, GA2LEN and WAO. Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Bookmark

Legends of Allergology/Immunology: Marcus Maurer (†)—Physician, Scientist, Allergist and Unbeatable Communicator

Key Points

Abstract

Cite This Study

Also Consider

Also Consider